Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
#90 most-disruptive IBD paper
802
Citations (OpenAlex)
637
Citations (NIH iCite)
-0.005
CD₅ disruption
Bibliometrics via OpenAlex (citations) and NIH iCite (disruption graph).
This page presents bibliographic and bibliometric information only; it does not reproduce the article abstract or full text. Read the article on PubMed or via the publisher link above. This paper appears on the IBDology all-time IBD literature leaderboards.
Educational and research-reference use only — not medical advice. IBDology curates the inflammatory bowel disease literature for clinicians and researchers.